1 hour ago
2
Syeda Seirut Javed
Sun, April 12, 2026 astatine 5:05 PM CDT 1 min read
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the stocks Jim Cramer discussed alongside the tech marketplace divide. Toward the extremity of the lightning round, a caller sought Cramer’s thoughts connected the company, and here’s what helium had to accidental successful response:
I deliberation Regeneron, I deliberation Leonard Schleifer’s doing an unbelievable job. I deliberation the stock’s breaking retired here, I truly do. I mean, I looked astatine it for the Charitable Trust, that and Amgen, we bought different stock, but those are the 2 I truly like.
A banal marketplace data. Photo by AlphaTradeZone connected Pexels
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) sells medicines for oculus conditions, immune disorders, cancer, cardiovascular issues, infections, and uncommon diseases. A caller inquired astir the banal during the March 2 episode, and Cramer replied:
Oh man, you cognize what? I should person pulled the trigger connected Regeneron erstwhile I sat down with them astatine the JPMorgan conference. I realized that the Charitable Trust should person owned it. It would’ve a overmuch better, truly overmuch amended cause banal than the others that we have, with the objection of Eli Lilly.
While we admit the imaginable of REGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years
Disclosure: None. Follow Insider Monkey connected Google News.
.png)
English (CA) · 
English (US) · 
Spanish (MX) ·